China’s A-share market closed lower across the board on Tuesday, with all major indices ending in negative territory. The benchmark Shanghai Composite Index declined 0.40%, while the Shenzhen Component Index dropped 0.86% and the ChiNext Index fell 1.17%. The Beijing Stock Exchange 50 Index also retreated 1.01%, with over 4,000 stocks closing lower in a broad market sell-off.
Despite the overall weakness, trading activity remained robust with total market turnover reaching 1.45 trillion yuan, up 138.6 billion yuan from the previous session. The healthcare sector emerged as a bright spot, with innovation drug ETFs leading the gains. The Hang Seng Innovation Drug ETF (159316) surged 4.08%, while the Hong Kong Stock Exchange Innovation Drug ETF (159567) and Hong Kong Stock Connect Innovation Drug ETF (159570) rose 3.81% and 3.69% respectively, reflecting strong investor interest in the biopharmaceutical sector.
The market’s mixed performance highlights ongoing sector rotation, with defensive healthcare names attracting capital while broader indices faced selling pressure. The increased trading volume suggests active repositioning by institutional investors amid current market conditions.
Related topics:
